Benad Goldwasser

Benad Goldwasser founded VidaMed, Inc. in 1993, where he worked as Principal, G.I.
View Ltd. in 2004, where he worked as Chief Executive Officer from 2004 to 2009, and Medinol Ltd. in 1992, where he worked as Principal.
Dr. Goldwasser also founded Optonol Ltd., US Healthcare, Inc., where he worked as Chief Executive Officer, and RITA Medical Systems, Inc., where he worked as Principal.
Dr. Goldwasser also currently works at Odysight.ai, Inc., as Executive Chairman, Safe Foods Corp., as Chairman from 2018, Leadexx Ltd., as Chairman, Scoutcam Ltd., as Chairman from 2019, Goldwasser Investments, Inc., as Director, Goldmed Ltd., as Director, Innoventric Ltd., as Director from 2017, and MediTech Partners, Inc., as Venture Partner.
Dr. Goldwasser also formerly worked at Nexentis Technologies, Inc., as Chairman from 2018 to 2021, Sheba Medical Center, as Chairman-Urology, Xylo Technologies Ltd., as Chairman from 2018 to 2019, Surgix Ltd., as Chairman, QTREX Quantum Ltd., as Chairman from 2021 to 2025, Anchiano Therapeutics Ltd., as Independent Director from 2013 to 2016, Biomedical Investments, as Managing Director in 1997, Scinai Immunotherapeutics Ltd., as Independent Director, Save Foods Ltd., as Director, Phytotech Medical Ltd., as Non Executive Director in 2015, Emerald Medical Applications Ltd., as Director in 2016, Underwood Capital Ltd., as Executive Director, Quantum X Labs, Inc., as Director in 2016, PhytoTech Therapeutics Ltd., as Director, and Tel-Aviv University, as Professor-Surgery.
Dr. Goldwasser received his doctorate degree in 1975 from Tel-Aviv University and Masters Business Admin degree in 1997 from Tel-Aviv University.